Vivos Inc. (OTCMKTS:RDGL) Sees Significant Decline in Short Interest

Vivos Inc. (OTCMKTS:RDGL) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 75,000 shares, a decrease of 19.9% from the February 28th total of 93,600 shares. Based on an average daily volume of 822,100 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

Vivos Stock Performance

OTCMKTS:RDGL traded up $0.00 during mid-day trading on Tuesday, hitting $0.12. The company had a trading volume of 432,421 shares, compared to its average volume of 1,011,757. Vivos has a fifty-two week low of $0.06 and a fifty-two week high of $0.26. The firm has a market cap of $55.31 million, a P/E ratio of -12.20 and a beta of 0.89. The business’s fifty day moving average is $0.13 and its two-hundred day moving average is $0.13.

About Vivos

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.